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Abstract 
 
Background: Growing evidence suggests a protective effect of volatile anaesthetics in 
ischaemia-reperfusion (I/R)-injury. The accumulation of neutrophils is crucial for the 
development of I/R-injury. Pro-inflammatory cytokines carrying the C-X-C-motif 
including interleukin-8 (IL-8) and CXC-ligand 1 (CXCL1) activate CXC receptor-1 
(CXCR1; IL-8) and/or CXC receptor-2 (CXCR2; IL-8, CXCL1) to induce CD11b-
dependent neutrophil transmigration. Inhibition of CXCR1 and/or CXCR2 reduces I/R-
injury by preventing neutrophil accumulation. We hypothesized that interference with 
CXCR1/CXCR2 signalling contributes to the well-established beneficial effect of volatile 
anaesthetics in I/R-injury. 
Methods: Isolated human neutrophils were stimulated with IL-8 or CXCL1 and exposed 
to volatile anaesthetics (sevoflurane/desflurane). Neutrophil migration was assessed 
using an adapted Boyden chamber. Expression of CD11b, CXCR1 and CXCR2 was 
measured by flow cytometry. Blocking antibodies against CXCR1/CXCR2/CD11b and 
phorbol myristate acetate served to investigate specific pathways.  
Results: Volatile anaesthetics reduced CD11b-dependent neutrophil transmigration 
induced by IL-8 by >30% and CD11b-expression by 18% and 27% with 
sevoflurane/desflurane, respectively. This effect was independent from CXCR1/CXCR2 
expression and CXCR1/CXCR2 endocytosis. Inhibition of CXCR1-signalling did not 
affect downregulation of CD11b with volatile anaesthetics. Blocking of CXCR2-signalling 
neutralized effects of volatile anaesthetics on CD11b-expression. Specific stimulation of 
CXCR2 with CXCL1 was sufficient to induce upregulation of CD11b, which was 
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impaired with volatile anaesthetics. No effect of volatile anaesthetics was observed with 
direct stimulation of protein kinase C located downstream of CXCR1/CXCR2. 
Conclusion: Volatile anaesthetics attenuate neutrophil inflammatory responses elicited 
by CXC cytokines through interference with CXCR2 signalling. This might contribute to 
the beneficial effect of volatile anaesthetics in I/R-injury. 
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Introduction  
 
 Ischaemia-reperfusion injury (I/R-injury) during anaesthesia occurs as an 
unforeseen event, e.g. transient myocardial ischaemia or as a planned step in surgery 
such as the Pringle manoeuvre during liver resection. Volatile anaesthetics protect 
different organs from I/R-injury such as liver, lung and heart.1-3 However, the 
mechanism of this protective effect has not been entirely elucidated. 
 The restoration of blood flow following ischaemia activates innate and adaptive 
immune responses leading to an accumulation of neutrophils in the reperfused organ 
and subsequent tissue damage.4 Consequently, inhibition of neutrophil invasion during 
reperfusion was demonstrated to reduce the extent of tissue damage.5-7  
The accumulation of neutrophils in I/R-injury is the result of a three-step process: First, 
circulating neutrophils establish a low-affinity adhesive interaction with the endothelium 
called rolling.8 This rolling is mediated by L-selectin (CD62L), which belongs to the 
family of glycoproteins on the neutrophil surface that binds endothelial carbohydrate 
determinants. In a second step, the neutrophil adheres firmly to the endothelium 
through adhesion between integrins on the neutrophil surface and endothelial 
intercellular adhesion molecules. The most prominent integrin during this process is 
CD11b, which binds to endothelial intercellular adhesion molecule-1. The third and final 
step, which involves various adhesive glyoproteins including CD62L and CD11b, is the 
transmigration of the neutrophil through the endothelium.  
 The family of CXC cytokines is defined by two N-terminal cystines seperated by 
one amino acid (hence C-X-C). A subgroup of these CXC cytokines carries a Glu-Leu-
  
7 
Arg tripeptide (ELR) motif at the NH2-end and is termed ELR+ CXC cytokines. This 
subgroup includes interleukin-8 (IL-8) and promotes the recruitment of neutrophils into 
inflamed tissues.9 ELR+ cytokines bind to two G protein-coupled receptors on the 
neutrophil surface, CXC receptor 1 (CXCR1) and CXC receptor 2 (CXCR2).10 11 
Signalling through these receptors is important during I/R-injury and pharmacologic 
inhibition was demonstrated to reduce neutrophil infiltration and subsequent tissue 
damage.12 
 We hypothesized that the beneficial effects of volatile anaesthetics during I/R-
injury are due to direct or indirect effects on CXCR1 and CXCR2 signalling that might 
alter the aforementioned process of neutrophil accumulation. We chose IL-8 as a 
representative ELR+ cytokine as it binds to both CXCR1 and CXCR2 with high affinity 
and is released by leukocytes and stromal cells such as fibroblasts in high 
concentrations during reperfusion.13-16 
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Methods  
 
 The study protocol was approved by the ethic committee for studies on humans 
of the University Hospital Zurich (KEK-ZH 2012-0274) and written informend consent 
was obtained. Five ml of blood were taken from healthy volunteers by puncture of the 
cephalic vein. A total of 12 volunteers (7 male/5 female, aged 19 - 52 years) were 
recruited from the Institute of Physiology in Zurich. All institute members between 18 
and 65 years old were considered eligible. Exclusion criteria were acute disease in the 
last 14 days or chronic disease with or without medical treatment of any kind. Oral 
contraceptives were accepted for female donors. All potential donors were interviewed 
by a medical doctor for these criteria and for informed consent prior to blood donation. 
Citrate was used as anticoagulant. Red blood cells were lysed and neutrophils were 
isolated using Ficoll-Histopaque 1077 (Sigma Aldrich, Buchs, Switzerland) as described 
before.17 The neutrophils were resuspended at a concentration of 2x106/ml in Ham´s F-
12 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 5% 
penicillin/streptomycin (10000U/l) and 5% 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (all from Invitrogen/life technologies, Zug, Switzerland). 
All steps were performed at 4°C to prevent neutrophil activation.  
 Fifty µl of neutrophil cell suspension (105 neutrophils) were placed into sterile 96-
well plates and exposed to 10nM IL-8 (recombinant human IL-8, BD Pharmingen, 
Allschwil, Switzerland) or 200ng ml-1 CXCL1 (recombinant human CXCL1, R&D 
systems, Wiesbaden, Germany). Phorbol myristate acetate at 10nM (Sigma-Aldrich, 
Buchs, Switzerland) was used to activate protein kinase C in the corresponding 
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experiments. These concentration are commonly used and known to induce profound 
neutrophil activation and migration. To study the effect of ischaemia-reperfusion in our 
setting, human lung microvascular endothelial cells were exposed to 12h of hypoxia 
(0.2% O2), followed by 12h of reoxygenation at 21% O2. Neutrophils were then 
stimulated with the harvested supernatants at 1:1 dilution. 
 
In some experiments, neutrophils were incubated for 15 min prior to stimulation with 
10µg ml-1 of specific antibodies directed against CXCR1 or CXCR2 (anti-human CXCR1 
and anti-human CXCR2, Abcam, Cambridge, UK) or against the activation epitope of 
CD11b (anti-human CBRM1/5, Biolegend, Lucerne, Switzerland). Plates were then put 
in humified airtight chambers (Oxoid anaerobic jar; Oxoid AG, Basel, Switzerland). 
Chambers were flushed with an air/5% CO2 mixture for 5 min that was optionally 
augmented with sevoflurane (Sevorane®; Abbott AG, Baar, Switzerland, corresponding 
vaporizer: Sevotec5®; Abbott AG) or with desflurane (Forene®, Baxter, Switzerland; 
corresponding vaporizer: Tec6, Carbamed, Switzerland) to a concentration of 2.2 Vol% 
sevoflurane or 6 Vol% desflurane, respectively. Control cells were exposed to air/5% 
CO2 only. Neutrophils from each donor were investigated under all three conditions 
(air/5% CO2 only, air/5% CO2 + sevoflurane, air/5% CO2 + desflurane). Concentrations 
of volatile anaesthetics were measured with the Ohmeda 5330 Agent Monitor (Abbott 
AG, Baar, Switzerland). After reaching the described concentrations in the chambers, 
they were sealed and kept in an incubator at 37°C (Bioblock, Ittingen, Switzerland). 
Volatile anaesthetic concentrations were checked again at the end of the incubation 
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period to ensure there was no loss of anaesthetic concentration in the chamber from 
insufficient sealing and evaporation.17 
 A 96-well migration plate with 3µm pores (Millipore-Merck, Zug, Switzerland) was 
used to investigate neutrophils migration. Fifty µl of neutrophil suspension (105 cells) 
were added to the upper compartment of the plate. Medium supplemented with 10nM 
IL-8 was added to the lower compartment. Plates were exposed to volatile anaesthetics 
as described above immediatly after assembly of the plate. Neutrophils were allowed to 
migrate for 1 hour. Migrated neutrophils were quantified using an automated optical cell 
counter (TC-10, Biorad, Cressier, Switzerland). 
 Surface expression of CXCR1, CXCR2, CD11b and CD11b activation epitope 
was quantified using flow cytometry. Neutrophils were kept on ice and fixed with 2% 
paraformaldehyde to prevent changes in receptor expression during staining. Cells were 
stained with specific antibodies for 30 min at 4°C, washed twice and measured on a 
FACS Canto II (BD Pharmingen, Allschwil, Switzerland). Flow cytometry raw data was 
analyzed using the FlowJo-Software for Macintosh (version 8.8.6, Tree Star Inc., 
Ashland, USA). The following mouse-anti human antibodies were used (all antibodies 
from BD Pharmingen, Allschwil, Switzerland): APC-Cy7-conjugated CD11b (final 
staining concentration 2µg ml-1); APC-conjugated CXCR1 (1.25µg ml-1); FITC-
conjugated CXCR2 (0.25µg ml-1). FITC-conjugated CBRM1/5 (0.2µg ml-1) was obtained 
from Biolegend, Lucerne, Switzerland. Appropriate isotype-control antibodies were used 
to quantify unspecific binding. 
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 Neutrophil viability was quantified by staining the cells with annexin-V and 7-
aminoactinomycin (PE Annexin V Apoptosis Detection Kit I, BD Pharmingen, Allschwil, 
Switzerland).  
 IL-8 concentration in supernatant was quantified using an enzyme-linked 
immunosorbent assay according the manufacturers protocol (R&D systems, 
Wiesbaden, Germany). This kit has a sensitivity range from 31.2pg ml-1 to 2000pg ml-1. 
All samples were diluted to archieve a sample concentration in the linear range of this 
assay.  
 Normal distribution of the data was assessed using the Kolmogorow-Smirnow 
test. Normally distributed data was analysed using one-way ANOVA with Bonferroni 
post-hoc test. Non-normally distributed data  were analysed with a Kruskal-Wallis test 
with Dunn’s multiple comparison test. All data are expressed as box plots with whiskers 
representing the minimum and maximum of all the values. All experiments were 
performed with blood from 3 or more different donors with conditions repeated in 
duplicates. A p-value of <0.05 was considered significant. Statistical analyses and graph 
creation were executed with Graphpad Prism 6 for Mac (Graphpad Software, La Jolla, 
USA). 
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Results  
 
 Our isolation procedure yielded neutrophils with a purity of >94% with <1% of 
dead cells (defined as cells staining positive for 7-aminoactinomycin, data not shown). 
Exposure to volatile anaesthetics did not reduce neutrophil viability (Figure 1). 
 We first investigated the functional effect of IL-8 on neutrophil transmigration. 
Interleukin-8 induced the transmigration of 43% of neutrophils within one hour. This was 
impaired to a comparable extent when neutrophils were exposed to sevoflurane or 
desflurane during migration (Figure 2A; 36% and 32% less transmigration with 
sevoflurane and desflurane, respectively; p=0.012 for sevoflurane, p=0.032 for 
desflurane). We found that neutrophil transmigration in this setting was dependent upon 
CD11b and abbrogated by CD11b-blocking antibodies (supplemental Figure 1). 
Accordingly, upregulation of CD11b following stimulation with IL-8 was attenuated by 
both, sevoflurane and desflurane (Figure 2B; p=0.013 for sevoflurane, p=0.001 for 
desflurane). Staining for the activation-epitope of CD11b revealed a similiar pattern with 
lower levels of activated CD11b in neutrophils exposed to sevoflurane and desflurane 
(Figure 2C;  p=0.002 for sevoflurane, p=0.02 for desflurane). Reduction of CD11b 
expression with volatile anaesthetics was also observed when neutrophils were 
stimulated with supernatants derived from hypoxia/reoxygenation-exposed endothelial 
cells (supplemental Figure 2). 
 We next asked whether these effects of volatile anaesthetics might be 
attributable to alternations of the IL-8 target receptors CXCR1 and CXCR2 on the 
neutrophil surface or their downstream pathways. Stimulation with IL-8 lead to strong 
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endocytosis and therefore reduction of surface expression of CXCR1 by 47% and 
CXCR2 by 81% (Figure 3A; p<0.0001). Neither sevoflurane nor desflurane affected this 
process. Also, baseline CXC receptor expression in resting neutrophils was not affected 
by volatile anaesthetics (p=0.9 for sevoflurane vs air, p=0.6 for desflurane vs air; data 
not shown). The extent of endocytosis of the ligand-receptor complexes formed by IL-8 
and CXCR1 or CXCR2 lead to a consumption and hence decrease of free IL-8 in the 
medium during incubation (Figure 3B, reduction of 31% after 1h of incubation 
compared to control medium without neutrophils, dashed line; p=0.008). Again, this was 
not influenced by sevoflurane or desflurane (Figure 3B, sevoflurane vs air p=0.999; 
desflurane vs air p=0.357).  
 Downstream effects of CXCR1 or CXCR2 activation include formation of 
diacylglycerol through phospholipase C, which activates protein kinase C. Direct 
stimulation of protein kinase C with phorbol myristate acetate, an analogue of 
diacylglycerol, lead to a strong upregulation of CD11b. No effect of sevoflurane and 
desflurane was observed in this setting (p>0.9 for sevoflurane vs air; p>0.9 for 
desflurane vs air, data not shown). 
 Using blocking antibodies against CXCR1 and CXCR2, we found that both 
receptors participate in the upregulation of CD11b in response to IL-8 (Figure 4A; 58% 
decrease following blocking of CXCR1, p<0.001; 36% decrease following blocking of 
CXCR2, p=0.01). However, the impaired upregulation of CD11b with sevoflurane and 
desflurane seems to be due to interference with pathways downstream of CXCR2 
exclusively: blocking of CXCR2 prior to stimulation neutralized the effect of volatile 
anaesthetics, while blocking of CXCR1 resulted in a preserved attenuation of CD11b 
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with sevoflurane and desflurane (Figure 4B; p<0.05 for sevoflurane and desflurane). In 
addition, stimulation with CXCL1, a CXC cytokine that exclusively activates CXCR2, 
readily reproduced the aforementioned effect of volatile anaesthetics (Figure 4C; 
p<0.01 for sevoflurane, p<0.001 for desflurane). 
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Conclusions 
 
 Our study demonstrates that volatile anaesthetics interfere with neutrophil 
inflammatory pathways, leading to decreased neutrophil migration and reduced 
expression of β2-integrin CD11b. We locate the site of action of volatiles anaesthetics to 
be downstream of CXCR2, a target receptor of ELR+ CXC cytokines that are involved in 
I/R-injury. 
 We focused the current study on the specific impact of volatile anaesthetics on 
neutrophil signalling through CXCR1 and CXCR2. The importance of the ELR+ family of 
cytokines that signals through these receptors is well established and their inhibition 
emerges as a new therapeutic option in I/R-injury.9 IL-8 is a suitable cytokine to 
represent the ELR+ family because of its high affinity to both of the ELR+ target 
receptors, CXCR1 and CXCR2.18 In addition, high levels of IL-8 are released during I/R-
injury, and neutralization of IL-8 was found to attenuate tissue damage during I/R-
injury.16 
 The accumulation of neutrophils in the reperfused organ following ischaemia is a 
multi-step process eventually leading to local tissue damage.4 Inhibition of this event 
through various means such as depletion of neutrophils or antibodies against neutrophil 
adhesion molecules leads to decreased tissue injury.7 19 The ability of neutrophils to 
transmigrate through the endothelium is pivotal for their accumulation in the reperfused 
organ. We found that sevoflurane and desflurane reduced the transmigration of 
neutrophils along an IL-8 gradient.  
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 The process of transmigration is known to be mediated by several neutrophil and 
endothelial adhesive proteins. However, inhibition of the neutrophil-endothelial 
interaction between CD11b on the neutrophil surface and endothelial intercellular 
adhesion molecule-1 proved to be most important.20 CD11b is critical to establish a tight 
adherence of the neutrophils to the endothelium, and failure to do so as by applying 
antibodies against CD11b significantly blocks neutrophil recruitment and reduces tissue 
damage both in vitro and in vivo.21 22 In our setting, neutrophil transmigration was 
dependent on CD11b expression. Accordingly, we found that both sevoflurane and 
desflurane attenuated the upregulation of CD11b in response to IL-8. These findings go 
in line with previous reports demonstrating an inhibition of the neutrophil-endothelial 
interaction with isoflurane and sevoflurane.23 24 
 To elucidate the site of action of volatile anaesthetics, the expression of the ELR+ 
receptors CXCR1 and CXCR2 which are activated by IL-8 was quantified in this study. 
These receptors undergo endocytosis upon ligand binding followed by a recycling step 
back to the membrane, which presumably serves to reduce neutrophil activity in 
response to high chemokine concentrations at inflammatory sites.25 We found that IL-8 
decreases the expression of CXCR1 and CXCR2. Exposure to volatile anaesthetics did 
not influence this effect, nor did it lead to a more pronounced downregulation in resting 
neutrophils. We further investigated the effect of endocytosis of the CXCR1 and CXCR2 
ligand-receptor-complex on free IL-8 levels. The strong decrease of membrane CXCR1 
and CXCR2, and hence high endocytosis of receptor-bound IL-8, lead to a diminished 
concentration of remaining available IL-8 in the medium. This was evident to the same 
extent when neutrophils were exposed to volatile anaesthetics. These observations 
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suggest that volatile anaesthetics do not induce changes in CXCR1 or CXCR2 surface 
expression and endocytosis which might have altered neutrophil activity.  
 Ligand binding to the G protein-coupled receptors CXCR1 and CXCR2 leads to 
dissemination of the G protein into the GTP-bound Gαi and the Gβγ subunit. Gαi then 
increases the activity of phosphatidyl-inositide-3 kinase while Gβγ activates 
phospholipase C. This leads to an increase of diacylglycerol that activates protein 
kinase C, which in turn induces CD11b expression.26 We found that phorbol myristate 
acetate, an analogue of diacylglycerol that directly activates protein kinase C without 
involvement of surface receptors, upregulates CD11b. However, no effect of volatile 
anaesthetics was observed in this setting. This suggests that volatile anaesthetics alter 
the neutrophil ELR+ pathway at a site upstream of protein kinase C. 
 We next aimed to investigate whether the effects of volatile anaesthetics were 
attributable to downstream pathways specific to CXCR1 or CXCR2. Indeed, blocking of 
CXCR2 abrogated the impact of both sevoflurane and desflurane on CD11b expression. 
On the contrary, blocking of CXCR1 preserved the effects of volatile anaesthetics, 
though at a lower level of CD11b expression. We then used CXCL1, a cytokine of the 
same family as IL-8, but which in contrast to IL-8 binds only to CXCR2. In line with the 
above findings, we found that stimulation with CXCL1 was sufficient to readily 
reproduce neutrophil inhibition with volatile anaesthetics. Sevoflurane and desflurane 
therefore seem to affect IL-8-induced neutrophil activation downstream of CXCR2. A 
particular role of CXCR2 during I/R-injury was also reported by Tarzami et al. who 
investigated the outcome of experimental myocardial infarction in CXCR2-/-(knockout) 
mice: not only did they find smaller infarct sizes as a correlate of decreased tissue 
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damage in CXCR2-/- mice, but they also observed a decreased number of infiltrating 
neutrophils in the infarcted area.27 In line with our finding, this suggest that CXCR2 
signalling is important for leukocyte recruitement in I/R-injury.   
 The current experimental setup uses an in vitro system of isolated neutrophils. 
This is a limitation of the current study as possible interactions of neutrophils with other 
cell types involved in I/R-injury as observed in vivo cannot be quantified. We chose this 
approach as it allows us to investigate pathways and inflammatory responses specific to 
neutrophils while avoiding expected or unanticipated cell-cell signalling.  
 Our results provide insight in how volatile anaesthetics can influence the 
accumulation of neutrophils in I/R-injury through inhibition of neutrophil migration and 
β2-integrin expression. Both, sevoflurane and desflurane, had comparable effects and 
seem to interfere within the CXCR2 signalling pathway at a site of action upstream of 
protein kinase C and downstream of CXCR2. Inhibition of CXCR2 signalling might 
therefore contribute to the well established anti-inflammatory effect of volatile 
anaesthetics for the development of I/R-injury in vivo. 
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Figure Legends  
Figure 1 
Volatile anaesthetics do not decrease neutrophil survival 
Resting or IL-8 stimulated neutrophils were incubated with either an air/5% CO2-
mixture, 2.2 Vol% of sevoflurane or 6 Vol% of desflurane. Viable neutrophils are defined 
as staining both negative for annexin and 7AAD (7-aminoactinomycin) (Annexin-/7AAD-, 
blue box plots). The amount of apoptotic neutrophils (Annexin+/7AAD-) are represented 
by green box plots, pink box plots show the amount of necrotic cells (Annexin+/7AAD+). 
n=6/group. 
 
Figure 2 
Volatile anaesthetics attenuate neutrophil transmigration and CD11b-upregulation 
A 105 neutrophils were seeded in the upper compartment of a modified Boyden 
chamber. Medium supplemented with 10nM IL-8 was added to the lower compartment. 
For control neutrophils, only medium was added to the lower compartment. Neutrophils 
were exposed to either an air/5% CO2-mixture, 2.2 Vol% of sevoflurane or 6 Vol% of 
desflurane during the 1 hour incubation. The number of neutrophils in the lower 
compartment at the end of the incubation period is given. Data are shown as box plots 
with whiskers from minimal to maximal value. #p<0.0001 vs control; *p<0.05 vs IL-8 
stimulated neutrophils exposed to air/5% CO2 during transmigration; n=9/group. 
B Neutrophils were stimulated with 10nM IL-8 and incubated for 1 hour in the presence 
or absence of 2.2% sevoflurane or 6% desflurane, respectively. The mean fluorescence 
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as assessed by flow cytometry of CD11b relative to unstimulated control neutrophils is 
given. #p<0.0001 vs unstimulated control neutrophils; *p<0.05 vs stimulated neutrophils 
exposed to air/5% CO2-mixture only; n=12/group. 
C Neutrophils were stimulated with IL-8 and exposed to volatile anaesthetics as 
described for 2B. The mean fluorescence as assessed by flow cytometry of the 
activation-epitope of CD11b-specific CBRM1/5 antibody clone relative to unstimulated 
control neutrophils is given. #p<0.001 vs unstimulated control neutrophils; *p<0.05 vs 
stimulated neutrophils exposed to air/5% CO2-mixture only; n=6/group. 
 
Figure 3  
A, B Volatile anaesthetics do not affect IL-8-induced CXCR1 and CXCR2 
internalization or IL-8 uptake in neutrophils 
A Neutrophils were stimulated with 10nM IL-8 and incubated for 1 hour in the presence 
of 2.2 Vol% of sevoflurane, 6 Vol% of desflurane or an air/5% CO2-mixture. CXCR1 (left 
panel) and CXCR2 (right panel) mean fluorescence relative to unstimulated control 
neutrophils is given. Box plots with whiskers from minimal to maximal value are shown. 
#p<0.001 vs unstimulated control neutrophils; n=6/group. 
B IL-8 concentration in medium was assessed by ELISA in the presence of neutrophils 
(PMN) after the addition of 10nM IL-8. Neutrophils were incubated at 37°C with either 
an air/5% CO2-mixture, 2.2 Vol% of sevoflurane or 6 Vol% of desflurane for 1 hour. The 
dashed line shows the measured IL-8 concentration in the absence of neutrophils 
(expected concentration for 10nM IL-8 is 80ng ml-1). p>0.3 for sevoflurane/desflurane vs 
stimulated neutrophils exposed to air/5% CO2-mixture only. n=8/group. 
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Figure 4 
Volatile anaesthetics affect CXCR2 
A Neutrophils were either left untreated, stimulated with 10nM IL-8 alone or incubated 
with anti-CXCR1- or anti-CXCR2-antibodies prior to stimulation with 10nM IL-8. CD11b 
expression was assessed using flow cytometry. The mean fluorescence of CD11b 
relative to unstimulated control neutrophils is given. Box plots with whiskers from 
minimal to maximal value are shown. #p<0.0001 vs control, *p<0.05 vs IL-8 alone; 
n=8/group. 
B Neutrophils were either left untreated or incubated with anti-CXCR1- or anti-CXCR2 
antibodies prior to stimulation with 10nM IL-8 and exposure to either an air/5% CO2-
mixture, 2.2 Vol% of sevoflurane or 6 Vol% of desflurane. The mean fluorescence of 
CD11b relative to unstimulated and non-treated control neutrophils is given. #p<0.0001 
vs untreated control, *p<0.05 vs air+IL-8; n=6/group. 
C Neutrophils were stimulated with 200ng ml-1 CXCL1 and incubated with either an 
air/5% CO2-mixture, 2.2 Vol% of sevoflurane or 6 Vol% of desflurane. The mean 
fluorescence as assessed by flow cytometry of CD11b relative to unstimulated control 
neutrophils is given. #p<0.05 vs control, *p<0.01 vs air+IL-8; n=6/group. 
 
 
Supplemental figure 1 
Neutrophil transmigration is CD11b-dependent 
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Neutrophils were seeded in the upper compartment of a modified Boyden chamber. 
Medium supplemented with 10nM IL-8 was added to the lower compartment. Anti-
CD11b blocking antibodies were added to the respective group of neutrophils. For 
control neutrophils, only medium was added to the lower compartment. Box plots show 
migrated neutrophils after 1h migration with whiskers representing minimal and maximal 
values. #p<0.001 vs control; *p<0.001 vs IL-8 stimulated neutrophils without Anti-CD11b 
antibodies; n=8/group. 
 
Supplemental figure 2 
Volatile anaesthetics attenuate CD11b-upregulation following 
hypoxia/reoxygenation 
Human lung microvascular endothelial cells were exposed to 12h of hypoxia (0.2% O2), 
followed by 12h of reoxygenation at 21% O2. Neutrophils were then stimulated with the 
harvested supernatants at 1:1 dilution for 1h in the presence of 2.2 Vol% of sevoflurane, 
6 Vol% of desflurane or an air/5% CO2-mixture. The mean fluorescence as assessed by 
flow cytometry of CD11b relative to unstimulated control neutrophils is given. Box plots 
with whiskers from minimal to maximal value are shown. #p<0.001 vs unstimulated 
control neutrophils; *p<0.05 vs stimulated neutrophils exposed to air/5% CO2-mixture 
only; n=6/group. 
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Figure 4A
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